The present invention provides a motor neuron degeneration inhibitor.　The present invention relates to a motor neuron degeneration inhibitor that contains one or more compounds selected from N-[3-({2-[(cyclopropanecarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl}oxy)phenyl]cyclohexanecarboxamide, 4-[(2-chlorophenoxy)methyl]-N-{1-[(2-fluorophenyl)methyl]-1H-pyrazol-4-yl}pyridine-2-carboxamide, N-[1-(4-fluorobutyl)-1H-pyrazol-4-yl]-4-[(2-fluorophenoxy)methyl]pyridine-2-carboxamide, 1-(3-chlorophenyl)-N-[4-(diethylcarbamoyl)phenyl]-2-methyl-1H-benzimidazole-6-carboxamide, 3-ethoxy-6-ethyl-N-[1-(hydroxyacetyl)piperidin-4-yl]-5-(4-methoxyphenyl)-1-methyl-4-oxo-4,5-dihydro-1H-pyrrolo[3,2-c]pyridine-2-carboxamide, 1-[(3-methoxyphenyl)methyl]-N-(pyridin-3-yl)-1H-benzotriazole-5-carboxamide, (3aS,4R,9bR)-4-[2-(trifluoromethyl)phenyl]-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline-8-carboxylic acid, 3-(pyridin-4-yl)-4,5-dihydro-2H-benzo[g]indazole, N-[4-(5-{[(4-chlorophenyl)methyl]sulfanyl}-4-methyl-4H-1,2,4-triazol-3-yl)phenyl]propanamide, 4-[(2-chlorophenoxy)methyl]-N-{1-[(2-cyanophenyl)methyl]-1H-pyrazol-4-yl}pyridine-2-carboxamide, 4-[(2-chlorophenoxy)methyl]-N-[1-(2-methoxyethyl)-1H-pyrazol-4-yl]pyridine-2-carboxamide, 1-(2-{[(4-methoxyphenyl)methyl]amino}pyrimidin-4-yl)-1H-indole-3-carboxamide, N-{3-[2-(4-methoxyphenyl)-1H-benzimidazol-5-yl]phenyl}-2-phenylacetamide, N-benzyl-2-cyclopropyl-5-methylthieno[2,3-d]pyrimidine-4-amine, and salts thereof.
MOTOR NEURON DEGENERATION INHIBITOR